Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_assertion type Assertion NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_head.
- NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_assertion description "[The results suggest using Rho-kinase inhibitors to reactivate the p53-PIG3 axis as a novel therapeutic strategy; we suggest that the use of antioxidants in melanoma should be very carefully evaluated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_provenance.
- NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_assertion evidence source_evidence_literature NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_provenance.
- NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_assertion SIO_000772 26464464 NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_provenance.
- NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_assertion wasDerivedFrom befree-2016 NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_provenance.
- NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_assertion wasGeneratedBy ECO_0000203 NP1294926.RAoaUD72RI3_TsyUKQ_E3yl-hXJbPRko4wxfD-9jNBJhk130_provenance.